English | Español

Regulatory
+ Regulatory
A. K. Alston | Jun 15, 2026

Health care reform group launches campaign linking consolidation to rising costs
+ Regulatory
A. A. Bolin | Jun 15, 2026

Public Policy Solutions on 340B: 'Lack of transparency and non-existent oversight have turned 340B into a massive grift'
+ Regulatory
Patient Daily | Jun 12, 2026

Taxpayer advocate: 340B drug discount program offers 'perverse incentives'
+ Regulatory
Patient Daily reports | Jun 11, 2026

Pharmacist Crisp on PBM reform bills: 'Middleman that owns the pharmacy, sets the price, pays itself, and audits its own books'
+ Regulatory
A. D. Ahrens | Jun 11, 2026

Economist: 'The 340B program has been hijacked by tax-exempt hospitals'
+ Regulatory
Patient Daily | Jun 10, 2026

Mark Cuban on PBMs and insurers: 'This is not an efficient market. We need to break them up'
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions
+ Regulatory
A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes